NTES [NetEase,] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page Page 3 Press Release Regarding Earnings Results for the Third Quarter of 2009, dated November 18, 2009]
NTES [NetEase,] 6-K: Form 6-K TABLE OF CONTENTS Page Page 3
[Form 6-K TABLE OF CONTENTS Page Page 3 Press Release Regarding Earnings Results for the Third Quarter of 2009, dated November 18, 2009]
NTES [NetEase,] 6-K: (Original Filing)
[Form 6-K SIZE="2">TABLE OFNTENTS Page Page 3 Press Release Regarding Earnings Results for the Third Quarter of 2009,ted November 18, 2009 NETEASE.COM, Onward Choi Acting Chief Financial Officer Press Releasentact for Media and Investors: STYLE="font-family:Times New Roman" SIZE="2"> Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 SIZE="2">LiJia NetEase.com,]
NTES [NetEase,] 6-K: (Original Filing)
[Form 6-K SIZE="2">TABLE OFNTENTS Page Page 3 Press Release Regarding Earnings Results for the Third Quarter of 2009,ted November 18, 2009 NETEASE.COM, Onward Choi Acting Chief Financial Officer Press Releasentact for Media and Investors: STYLE="font-family:Times New Roman" SIZE="2"> Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 SIZE="2">LiJia NetEase.com,]
NTES [NetEase,] 6-K: (Original Filing)
[Form 6-K SIZE="2">TABLE OFNTENTS Page Page 3 Press Release Regarding Earnings Results for the Third Quarter of 2009,ted November 18, 2009 NETEASE.COM, Onward Choi Acting Chief Financial Officer Press Releasentact for Media and Investors: STYLE="font-family:Times New Roman" SIZE="2"> Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 SIZE="2">LiJia NetEase.com,]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers Parties Party BACKGROUND WHEREAS 1933 Act Regulation D SEC WHEREAS Series B Preferred Stock Common Stock Securities WHEREAS NOW, THEREFORE Article 1 INCORPORATION BY REFERENCE AND DEFINITIONS 1.1 Incorporation by Reference 1.2 Supersedes Other Agreements 1.3 Certain Definitions PAGE 1 1.3.1 9.9% Limitation “ 1.3.2 1933 Act “ 1.3.3 “]
BSPM [Biostar Pharmaceuticals,] 8-K: SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company
[SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT Agreement Company Buyer Buyers Parties Party BACKGROUND WHEREAS 1933 Act Regulation D SEC WHEREAS Series B Preferred Stock Common Stock Securities WHEREAS NOW, THEREFORE Article 1 INCORPORATION BY REFERENCE AND DEFINITIONS 1.1 Incorporation by Reference 1.2 Supersedes Other Agreements 1.3 Certain Definitions PAGE 1 1.3.1 9.9% Limitation “ 1.3.2 1933 Act “ 1.3.3 “]
NTES [NetEase] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page Page 3 Press Release Regarding Earnings Results for the Third Quarter of 2009, dated November 18, 2009 NETEASE.COM, INC. /s/ Onward Choi Name: Onward Choi Title: Acting Chief Financial Officer Press Release Contact for Media and Investors: Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 LiJia]
NTES [NetEase] 6-K: Form 6-K TABLE OF CONTENTS Page Page 3
[Form 6-K TABLE OF CONTENTS Page Page 3 Press Release Regarding Earnings Results for the Third Quarter of 2009, dated November 18, 2009 NETEASE.COM, INC. /s/ Onward Choi Name: Onward Choi Title: Acting Chief Financial Officer Press Release Contact for Media and Investors: Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1)212-481-2050 LiJia]
CSUN [China Sunergy] 6-K: (Original Filing)
[CHINA SUNERGY ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2009 Third Quarter Revenues of US$80.1 million; Achieves Upper Range of Guidance with 54.4 MW in Shipments; Gross Margin Improves to 10.2%; GAAP Net Income of $7.8 million Nanjing, China – November 18, 2009 – China Sunergy Co., Ltd. (Nasdaq: CSUN), (“China Sunergy” or the “Company”) a specialized solar cell]
